In a recent study posted on bioRxiv* Preprint server, researchers evaluated the efficiency of lipid nanoparticles against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). study: Delivery...
Antibodies induced after coronavirus disease 2019 (COVID-19) vaccination or SARS-CoV-2 infection have the ability to cross-neutralize the variant of concern (VOC). It is declining. However, antibodies...
In a recent study posted on bioRxiv* Preprint server, researchers found the original Wuhan-Hu 1 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) strain, Alpha, Delta, Delta-plus...
In a recent study posted on bioRxiv* Preprint server, researchers investigated changes in levels of cyclins and cyclin-dependent kinases (CDKs) in host cells caused by coronavirus...
In a recent study published in iScience Journals and researchers have evaluated potential targets for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). study: Prediction of anti-SARS-CoV-2...
The emergence of Omicron, the latest concern (VOC) for coronavirus 2 (SARS-CoV-2), has fueled concerns about vaccines. Effectiveness And the ability of the immune system induced...
Recent Comments